Notice of Intent To Grant Partially Exclusive License, 35480 [2011-15025]

Download as PDF 35480 Federal Register / Vol. 76, No. 117 / Friday, June 17, 2011 / Notices Administration, U.S. Department of Labor, Room N–5428, 200 Constitution Avenue, NW., Washington, DC 20210. Signed at Washington, DC, this 10th day of June 2011. Michael W. Jaffe, Certifying Officer, Office of Trade Adjustment Assistance. Appendix TAA PETITIONS INSTITUTED BETWEEN 5/30/11 AND 6/3/11 Subject firm (petitioners) Location Zeledyne Glass Plant (Company) ............................................................... Starks Manufacturing (State/One-Stop) ...................................................... Nidec Motor Corporation (Company) .......................................................... West Clermont School (State/One-Stop) .................................................... Tecumseh Products Corporation (Workers) ............................................... General Motors Component Holdings (GMCH) (Union) ............................. MedTec Ambulance Corporation (Workers) ............................................... United Solar Ovonics (State/One-Stop) ...................................................... Ringo B.D. Inc (Company) .......................................................................... Unlimited Services (Company) ................................................................... Healthlink (Workers) .................................................................................... California Newspaper Limited Partnership (Company) .............................. Dex One (Workers) ..................................................................................... Solar Power Industries (Company) ............................................................. Tulsa, OK .................. Russellville, AR ......... Frankfort, IN .............. Cincinnati, OH ........... Ann Arbor, MI ............ Rochester, NY ........... Bradenton, FL ........... Greenville, MI ............ Passaic, NJ ............... Oconto, WI ................ St. Louis, MO ............ Vallejo, CA ................ Cary, NC ................... Mount Pleasant, PA .. TA–W 80203 80204 80205 80206 80207 80208 80209 80210 80211 80212 80213 80214 80215 80216 ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... [FR Doc. 2011–15086 Filed 6–16–11; 8:45 am] BILLING CODE 4510–FN–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (11–052)] Notice of Intent To Grant Partially Exclusive License National Aeronautics and Space Administration. ACTION: Notice of intent to grant partially exclusive license. AGENCY: This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in USPN 6,047,216, Endothelium Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC–22724–1, USPN 6,226,553, Endothelium Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC– 22724–2, USPN 6,223,086, Endothelium Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC– 22724–3, and USPN 6,496,736, Endothelium Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC–22724–5 to Meridian Health Systems, P.C., having its principal place of business in Los Angeles, California. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the emcdonald on DSK2BSOYB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:39 Jun 16, 2011 Jkt 223001 National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. DATES: The prospective partially exclusive license may be granted unless within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. ADDRESSES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, 2101 NASA Parkway, Houston, Texas 77058, Mail Code AL; Phone (281) 483– 3021; Fax (281) 483–6936. FOR FURTHER INFORMATION CONTACT: Theodore U. Ro, Intellectual Property Attorney, Office of Chief Counsel, 2101 NASA Parkway, Houston, Texas 77058, Mail Code AL; Phone (281) 244–7148; Fax (281) 483–6936. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov/. PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Date of institution 05/31/11 05/31/11 05/31/11 05/31/11 05/31/11 06/01/11 06/01/11 06/02/11 06/03/11 06/03/11 06/03/11 06/03/11 06/03/11 06/03/11 Date of petition 05/27/11 05/27/11 05/26/11 05/27/11 05/19/11 05/27/11 05/23/11 06/01/11 06/01/11 06/01/11 05/30/11 06/01/11 06/02/11 06/02/11 Dated: June 13, 2011. Richard W. Sherman, Deputy General Counsel. [FR Doc. 2011–15025 Filed 6–16–11; 8:45 am] BILLING CODE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (11–053)] Notice of Intent To Grant Exclusive License National Aeronautics and Space Administration. ACTION: Notice of intent to grant exclusive license. AGENCY: This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive patent and copyright license in the United States to practice the invention(s) and computer software described in NASA Case No. LAR– 17980–1, entitled ‘‘Space Utilization Optimization Tools,’’ to T3W Business Solutions, Inc., having its principal place of business in San Diego, California. The patent rights and copyright in the invention(s) and computer software will be assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. SUMMARY: E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 76, Number 117 (Friday, June 17, 2011)]
[Notices]
[Page 35480]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-15025]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (11-052)]


Notice of Intent To Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant partially exclusive license.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
a partially exclusive license in the United States to practice the 
inventions described and claimed in USPN 6,047,216, Endothelium 
Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC-
22724-1, USPN 6,226,553, Endothelium Preserving Microwave Treatment For 
Atherosclerosis, NASA Case No. MSC-22724-2, USPN 6,223,086, Endothelium 
Preserving Microwave Treatment For Atherosclerosis, NASA Case No. MSC-
22724-3, and USPN 6,496,736, Endothelium Preserving Microwave Treatment 
For Atherosclerosis, NASA Case No. MSC-22724-5 to Meridian Health 
Systems, P.C., having its principal place of business in Los Angeles, 
California. The patent rights in these inventions have been assigned to 
the United States of America as represented by the Administrator of the 
National Aeronautics and Space Administration. The prospective 
partially exclusive license will comply with the terms and conditions 
of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless within fifteen (15) days from the date of this published notice, 
NASA receives written objections including evidence and argument that 
establish that the grant of the license would not be consistent with 
the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing 
applications completed and received by NASA within fifteen (15) days of 
the date of this published notice will also be treated as objections to 
the grant of the contemplated partially exclusive license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, 2101 NASA 
Parkway, Houston, Texas 77058, Mail Code AL; Phone (281) 483-3021; Fax 
(281) 483-6936.

FOR FURTHER INFORMATION CONTACT: Theodore U. Ro, Intellectual Property 
Attorney, Office of Chief Counsel, 2101 NASA Parkway, Houston, Texas 
77058, Mail Code AL; Phone (281) 244-7148; Fax (281) 483-6936. 
Information about other NASA inventions available for licensing can be 
found online at https://technology.nasa.gov/.

    Dated: June 13, 2011.
Richard W. Sherman,
Deputy General Counsel.
[FR Doc. 2011-15025 Filed 6-16-11; 8:45 am]
BILLING CODE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.